Phase I, Open-Label, Study of Tumor Infiltrating Lymphocytes Engineered With Membrane Bound IL15 Plus Acetazolamide in Adult Patients With Metastatic Melanoma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Maastricht University Medical Center
The Christie NHS Foundation Trust
Centre Oscar Lambret
Mayo Clinic
University of Pittsburgh
University of Florida
Essen Biotech
Essen Biotech
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
Cancer Research UK
University Health Network, Toronto
Cancer Research UK
Cancer Research UK
Cancer Research UK
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
Young Adult Survivors United
Institut Bergonié
Institut Curie
UNC Lineberger Comprehensive Cancer Center
Oregon Health and Science University
Washington University School of Medicine
University of Florida
Ahvaz Jundishapur University of Medical Sciences
Milton S. Hershey Medical Center
Semmelweis University
University of Pittsburgh
Institut Claudius Regaud
NuCana plc
University of Arkansas
Duke University
University of Arizona
N.N. Petrov National Medical Research Center of Oncology
University of Alberta
Rabin Medical Center
Stanford University
University of Aarhus
Inova Health Care Services
Cedars-Sinai Medical Center
University Health Network, Toronto
Melanoma and Skin Cancer Trials Limited
Melanoma and Skin Cancer Trials Limited
German Cancer Research Center
University of California, San Diego
University Hospitals Coventry and Warwickshire NHS Trust